BTAI BioXcel Therapeutics
BioXcel Therapeutics earnings company data as of 7:30 PM ET 8/20
- 1 of 1 EPS beats
History
1 period · newest first · EPS & Rev stacked
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q2 | 13 Aug | EPS | -0.58 | -0.49 | Beat |
| Rev | — | — | — |
SEC filings
Recent issuer filings from EDGAR · 18 shown · open Filing / Doc on SEC.gov
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 1.01,1.03 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 3.02,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 424B5 | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 8-K | 8.01 | Filing Doc |
No filings match this filter.
Insider forms
Form 3 / 4 / 5 from EDGAR · 2 rows shown
Consensus estimates · SEC filings remain the official record · not investment advice